Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.
about
A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s)Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines.Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region.Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1.Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine productionA multigene family that interacts with the amino terminus of plasmodium MSP-1 identified using the yeast two-hybrid systemA prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections.Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparumA recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bondsComparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.Malaria vaccine development.Expression and lytic efficacy assessment of the Staphylococcus aureus phage SA4 lysin geneRoles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.Specific T-cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum.A conserved region of the MSP-1 surface protein of Plasmodium falciparum contains a recognition sequence for erythrocyte spectrin.Cell invasion by the vertebrate stages of Plasmodium.
P2860
Q33599911-00B367AD-A36F-4515-80D1-8A0F98605BF0Q33605280-27D9F9A1-1CEB-4CAB-B26D-91558166612DQ33614847-8AB8B13F-5C96-4D81-9ADA-9BE44719BE67Q33757015-E7E188F8-8129-40DA-A4C4-CEE9925A7184Q34002481-6A695E73-F4EF-47C8-AD8C-22715F1C5DE2Q34003578-7281A7F3-AF13-4DF8-9CFE-1A3660A2DCA7Q34004267-7A525C1F-66EB-435D-8F82-54FCA09BEA0FQ34004431-3B4A5E49-FB66-4301-8370-F31C6D52390FQ34120959-76526E50-519B-42EF-8088-48938BB6B9A0Q34420625-861D5636-058E-4D34-A831-CA44E692E473Q34520456-92D56450-D28A-4382-860E-B618DDB6F206Q34541366-87367A6A-EB81-4570-8058-FAF23F71E22CQ35076906-8945BA85-3A69-4AD2-80C4-89B6EC3D88BCQ35383761-8DF1BF12-52F8-4C6D-87B0-5893D10147D5Q35463512-32DFB060-9172-47C5-8661-5536B6FD5719Q35486529-A9AEB107-2DF9-473E-ABEC-CABBCA4F33F6Q35504908-8B838F8F-6544-4E80-8F6A-F19F572C902DQ35519418-D9EDF257-4146-4CB0-83DE-C34A7D62648AQ35549892-27E4B160-8D10-4C39-BCE5-07FBC293A51CQ35551944-726E5441-1948-411B-B8A7-28BB5047C30BQ35551948-B9A8F4EF-031A-4723-84D5-4C4B7D81CB07Q36404193-19620BE4-0D11-4207-B2A5-491736F2DBABQ36641624-BFA5CABF-9BC8-48A8-BA14-D92C20D0F3C1Q36736576-155D5C4B-5D4E-4AF1-B008-D91EF85A7553Q36943106-151B35B3-374B-4E45-9C1E-4BB3AE1F88CBQ39572070-11737FAD-89F4-49B9-AFC2-34CBB1142733Q39655089-17107476-47BF-4314-9A65-750884878E1DQ40055186-BD46ACF3-4E0E-41D3-A9D4-9E4D09B701C8Q40373716-D180170E-B53C-48D3-9811-EEBF76AA10B8Q40872637-23A0E464-1C32-4CBE-97C6-9F8B2CA5C499Q41201670-6C1786AF-F4EB-4E65-93D3-9DAF177B75D7
P2860
Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Ability of recombinant or nati ...... ge with Plasmodium falciparum.
@en
type
label
Ability of recombinant or nati ...... ge with Plasmodium falciparum.
@en
prefLabel
Ability of recombinant or nati ...... ge with Plasmodium falciparum.
@en
P2093
P2860
P1476
Ability of recombinant or nati ...... nge with Plasmodium falciparum
@en
P2093
P2860
P304
P407
P577
1991-10-01T00:00:00Z